These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 36601502)

  • 21. Risk factors for acute kidney injury in critically ill patients receiving high intravenous doses of colistin methanesulfonate and/or other nephrotoxic antibiotics: a retrospective cohort study.
    Rocco M; Montini L; Alessandri E; Venditti M; Laderchi A; De Pascale G; Raponi G; Vitale M; Pietropaoli P; Antonelli M
    Crit Care; 2013 Aug; 17(4):R174. PubMed ID: 23945197
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacies of Colistin-Carbapenem versus Colistin-Tigecycline in Critically Ill Patients with CR-GNB-Associated Pneumonia: A Multicenter Observational Study.
    Wang SH; Yang KY; Sheu CC; Chen WC; Chan MC; Feng JY; Chen CM; Wu BR; Zheng ZR; Chou YC; Peng CK; On Behalf Of The T-Care Taiwan Critical Care Infection Group
    Antibiotics (Basel); 2021 Sep; 10(9):. PubMed ID: 34572663
    [No Abstract]   [Full Text] [Related]  

  • 23. Clinical outcome of nosocomial pneumonia caused by Carbapenem-resistant gram-negative bacteria in critically ill patients: a multicenter retrospective observational study.
    Chen CY; Yang KY; Peng CK; Sheu CC; Chan MC; Feng JY; Wang SH; Chen CM; Zheng ZR; Liang SJ; Lin YC;
    Sci Rep; 2022 May; 12(1):7501. PubMed ID: 35525867
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and toxicity of aerosolised colistin in ventilator-associated pneumonia: a prospective, randomised trial.
    Abdellatif S; Trifi A; Daly F; Mahjoub K; Nasri R; Ben Lakhal S
    Ann Intensive Care; 2016 Dec; 6(1):26. PubMed ID: 27033711
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intravenous combined with aerosolised polymyxin versus intravenous polymyxin alone in the treatment of pneumonia caused by multidrug-resistant pathogens: a systematic review and meta-analysis.
    Liu D; Zhang J; Liu HX; Zhu YG; Qu JM
    Int J Antimicrob Agents; 2015 Dec; 46(6):603-9. PubMed ID: 26607337
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Colistin induced acute kidney injury in critically ill children: a prospective study utilizing RIFLE criteria.
    Meysam S; Khosravi Z; Rashti R; Qorbani M; Assadi F; Hayatshahi A; Parin T; Faghihi T
    Daru; 2022 Jun; 30(1):11-15. PubMed ID: 34807396
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Colistin therapy in critically ill patients with chronic renal failure and its effect on development of renal dysfunction.
    Turkoglu M; Dizbay M; Ciftçi A; Aksakal FN; Aygencel G
    Int J Antimicrob Agents; 2012 Feb; 39(2):142-5. PubMed ID: 22115538
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The efficacy and nephrotoxicity associated with colistin use in an intensive care unit in Vietnam: Use of colistin in a population of lower body weight.
    Binh NG; Hayakawa K; Co DX; Tuan ND; Anh NH; Thuy NT; Phuong DM; Huong NT; Thuy PT; Chau NQ; Nhung PH; Gam do TH; Hai DT; Huong TT; Van Anh L; Takeshita N; Ohmagari N
    Int J Infect Dis; 2015 Jun; 35():18-23. PubMed ID: 25835100
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-dose colistin for microbiologically documented serious respiratory infections associated with carbapenem-resistant Acinetobacter baummannii in critically ill cancer patients: a retrospective cohort study.
    Nazer LH; Rihani S; Hawari FI; Le J
    Infect Dis (Lond); 2015; 47(11):755-60. PubMed ID: 26050703
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incidence and risk factors of nephrotoxicity in patients on colistimethate sodium.
    Hassan MM; Gaifer Z; Al-Zakwani IS
    Int J Clin Pharm; 2018 Apr; 40(2):444-449. PubMed ID: 29542034
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The necessity of a loading dose when prescribing intravenous colistin in critically ill patients with CRGNB-associated pneumonia: a multi-center observational study.
    Wang SH; Yang KY; Sheu CC; Chen WC; Chan MC; Feng JY; Chen CM; Wu BR; Zheng ZR; Chou YC; Peng CK;
    Crit Care; 2022 Apr; 26(1):91. PubMed ID: 35379303
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute kidney injury during colistin therapy: a prospective study in patients with extensively-drug resistant Acinetobacter baumannii infections.
    Durante-Mangoni E; Andini R; Signoriello S; Cavezza G; Murino P; Buono S; De Cristofaro M; Taglialatela C; Bassetti M; Malacarne P; Petrosillo N; Corcione A; Viscoli C; Utili R; Gallo C
    Clin Microbiol Infect; 2016 Dec; 22(12):984-989. PubMed ID: 27545697
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of nebulized colistin as a substitutive strategy against nosocomial pneumonia caused by CR-GNB in intensive care units: a retrospective cohort study.
    Feng JY; Huang JR; Lee CC; Tseng YH; Pan SW; Chen YM; Yang KY
    Ann Intensive Care; 2023 Jan; 13(1):1. PubMed ID: 36609725
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Acute kidney injury following colistin treatment in critically-ill patients: may glucocorticoids protect?
    Heybeli C; Canaslan K; Oktan MA; Yıldız S; Arda HÜ; Çavdar C; Çelik A; Gökmen N; Cömert B
    J Chemother; 2021 Apr; 33(2):85-94. PubMed ID: 32500843
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of thiamine as adjunctive therapy in COVID-19 critically ill patients: a two-center propensity score matched study.
    Al Sulaiman K; Aljuhani O; Al Dossari M; Alshahrani A; Alharbi A; Algarni R; Al Jeraisy M; Al Harbi S; Al Katheri A; Al Eidan F; Al Bekairy AM; Al Qahtani N; Al Muqrin M; Vishwakarma R; Al Ghamdi G
    Crit Care; 2021 Jun; 25(1):223. PubMed ID: 34193235
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Effect of early initiation of continuous renal replacement therapy based on the KDIGO classification on the prognosis of critically ill patients with acute kidney injury].
    Chen M; Hu B; Li Q; Liu J
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2016 Mar; 28(3):246-51. PubMed ID: 29917340
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Survival implications vs. complications: unraveling the impact of vitamin D adjunctive use in critically ill patients with COVID-19-A multicenter cohort study.
    Al Sulaiman K; Korayem GB; Aljuhani O; Altebainawi AF; Shawaqfeh MS; Alarfaj SJ; Alharbi RA; Ageeli MM; Alissa A; Vishwakarma R; Ibrahim A; Alenazi AA; Alghnam S; Alshehri N; Alshammari MM; Alhubaishi A; Aldhaeefi M; Alamri FF; Syed Y; Khan R; Alalawi M; Alanazi KA; Alresayes FS; Albarqi KJ; Al Ghamdi G
    Front Med (Lausanne); 2023; 10():1237903. PubMed ID: 37692775
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative Incidence of Acute Kidney Injury in Critically Ill Patients Receiving Vancomycin with Concomitant Piperacillin-Tazobactam or Cefepime: A Retrospective Cohort Study.
    Hammond DA; Smith MN; Painter JT; Meena NK; Lusardi K
    Pharmacotherapy; 2016 May; 36(5):463-71. PubMed ID: 26952639
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association Between Dexamethasone and Delirium in Critically Ill Patients: A Retrospective Cohort Study of a Large Clinical Database.
    Wu Z; Li H; Liao K; Wang Y
    J Surg Res; 2021 Jul; 263():89-101. PubMed ID: 33639374
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of prognosis and nephrotoxicity in patients treated with colistin in intensive care unit.
    Gunay E; Kaya S; Baysal B; Yuksel E; Arac E
    Ren Fail; 2020 Nov; 42(1):704-709. PubMed ID: 32703065
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.